Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A statistical study on the survival rate].

K Fukuhisa, E Takeda

    Gan No Rinsho. Japan Journal of Cancer Clinics
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Evaluating cancer treatment requires accurate survival rate calculations. This study introduces a new "Cumulative effective survival rate" to account for treatment complications, improving cancer therapy assessment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Role of rBAT gene products in cystinuria.

    International journal of urology : official journal of the Japanese Urological Association·2014
    Same author

    Fast-neutron radiotherapy of nonsmall cell-carcinoma of the lung.

    International journal of oncology·2011
    Same author

    Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men.

    Kidney international·2006
    Same author

    Effect of late evening snack with rice ball on energy metabolism in liver cirrhosis.

    European journal of clinical nutrition·2006
    Same author

    Generalized eruptive histiocytoma with rapid progression and resolution following exanthema subitum.

    Clinical and experimental dermatology·2005
    Same author

    [Parathyroid hormone-mediated regulation of renal phosphate co-transporter].

    Clinical calcium·2005
    Same journal

    [A neuron-specific enolase (NSE) positive leiomyosarcoma].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [A case of synchronous multiple primary cancers of the stomach and kidney].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [A case of multiple peripheral pulmonary carcinoids showing a diffuse lung disease synchronously associated with sigmoid colon cancer].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [A well differentiated fibrosarcoma arising in left neck region].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [A giant struma histologically confirmed as a medullary carcinoma with multiple systemic bone metastasis].

    Gan no rinsho. Japan journal of cancer clinics·1990
    Same journal

    [Problems associated with radical neck dissection in patients with tongue carcinoma: four cases of stage I tongue carcinoma that recurred in the cervical area after the dissection].

    Gan no rinsho. Japan journal of cancer clinics·1990
    See all related articles

    Area of Science:

    • Oncology
    • Biostatistics
    • Medical Informatics

    Context:

    • Cancer treatment efficacy is often evaluated using survival rates.
    • Existing methods like crude survival rate and life table analysis have limitations, especially with censored data and rapid changes.
    • Radiation therapy can lead to normal tissue complications that impact long-term outcomes.

    Purpose:

    • To critically review various methods for calculating cancer patient survival rates.
    • To highlight the limitations of traditional survival rate calculations.
    • To propose a novel metric, the Cumulative Effective Survival Rate, for more accurate cancer therapy evaluation.

    Summary:

    • This paper examines survival rate calculation methods, advising against crude survival rates due to issues with censored data.

    Related Experiment Videos

  • It recommends re-computation at shorter intervals if life table or relative survival rates change rapidly.
  • A new metric, the Cumulative Effective Survival Rate, is introduced, integrating normal tissue complication data with relative survival rates.

    • Impact:

    • Provides a more nuanced and accurate assessment of cancer treatment effectiveness.
    • Offers a new tool for clinicians and researchers to evaluate long-term patient outcomes.
    • Facilitates better understanding of the trade-offs between cancer treatment efficacy and treatment-related toxicities.